New milestones in Asia-Pacific and North America reflect the growing use of spectral imaging in clinical and research settings.
KA Imaging is expanding the availability of its spectral X-ray technology following recent regulatory milestones in Asia-Pacific and a new research partnership in North America.
In Hong Kong, the company secured an Irradiating Apparatus License for its Reveal Mobi Pro and Mobi Lite mobile X-ray systems. Additionally, the Reveal Mobi Pro is now cleared for sale in Australia following a regulatory review.
“Across regions, we’re seeing consistent interest in approaches that add information to standard X-ray without adding complexity,” says Charlie Hicks, vice president of global medical sales, in a release. “That’s what is driving adoption of our SpectralDR technology, particularly in mobile and bedside settings.”
Expanding Research Applications
Alongside clinical growth, the company is expanding its presence in the research sector through a partnership with Scintica. This collaboration will bring a 3D X-ray imaging platform to preclinical and biomedical research groups across North America, supporting work in life sciences and materials.
“By bringing together phase-contrast imaging with inCiTe and high-resolution amorphous selenium technology with BrillianSe, we’re helping advance research and science,” says Jim Harp, vice president of non-destructive testing sales & business development, in a release.
According to the company, these developments coincide with new applications of X-ray imaging, including early-stage efforts in space-based research.
Shifting Clinical Workflows
The momentum reflects a broader shift in how X-ray technology is utilized within care pathways, according to a release from the company. In clinical settings, imaging is moving closer to where decisions are made, including the bedside, the emergency department, and outpatient workflows.
Rather than serving only as an initial step before more advanced imaging, X-ray is increasingly used to guide triage, support next steps, and inform follow-up, particularly in environments where patient condition or time limits other options.
A similar trend is occurring in research, where imaging is used to explore questions from the outset rather than just confirming results. Researchers are seeking ways to differentiate materials and study fine structures within a single scan to reduce the need for destructive testing.
“Our focus has been to build technology that fits into real-world settings,” says Amol Karnick, president and CEO, in a release. “What we’re seeing now is that this approach is resonating across very different markets, including security/defense, pharmaceuticals, and electric vehicles.”
The company’s core technology is designed for application across multiple contexts, from hospitals to research labs.
“The same core technology can be applied in many contexts, from hospitals to research labs to entirely new environments,” says Dr Karim S Karim, co-founder and chief technology officer, in a release. “That’s where a lot of our current work is focused.”
Photo caption: KA Imaging’s spectral X-ray technology
Photo credit: KA Imaging
